Brochure
26 Aug 2026
Generic API and Intermediate Product List
PDF 188 kB
Cambrex is a leading global supplier of generic APIs. We work with generic drug companies well in advance of drug patent expiration, using high-quality, non-patent infringing processes to manufacture APIs. We produce over 90 generic APIs, intermediates, derivatives, and chiral compounds, including controlled substances.To see the complete list of the products we manufacture, download our full product list.
Content provided by our supplier
Cambrex Profarmaco Milano
-
Country/Region:Italy
-
On CPHI since:2024
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
Other Content from Cambrex Profarmaco Milano (1)
-
News Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities
Cambrex announced the successful completion of three Pre-Approval Inspections (PAIs) at its High Point, North Carolina facility by the U.S. Food and Drug Administration (FDA), Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), and Australia’s Therapeutic Goods Administration (TGA). The completion of all three inspections enables High Point to manufacture approved active pharmaceutical ingredients (APIs) for the United States, Japan, and Australia, establishing the facility as the newest commercial manufacturing site within the Cambrex global network.